Author: Boku Narikazu Muro Kei Machida Nozomu Hashigaki Satoshi Kimura Nobuyuki Suzuki Mie Lechuga Mariajose Miyata Yoshinori
Publisher: Springer Publishing Company
ISSN: 0167-6997
Source: Investigational New Drugs, Vol.32, Iss.2, 2014-04, pp. : 261-270
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
By Lee K.-W. Park S. Oh D.-Y. Park Y.-I. Khosravan R. Lin X. Lee S.-Y. Roh E.-J. Valota O. Lechuga M. Bang Y.-J.
Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. :
By Kim Sun Hong Yong Kim Byung Park Ji Choi Hyo Jeong Seung-Yong Kim Dae Hong Chang Sohn Dae Jung Kyung
Investigational New Drugs, Vol. 27, Iss. 3, 2009-06 ,pp. :
By Yoo Changhoon Ryu Min-Hee Na Young-Soon Ryoo Baek-Yeol Lee Chae-Won Maeng Jeheon Kim Se-Yeon Koo Dong Park Inkeun Kang Yoon-Koo
Investigational New Drugs, Vol. 32, Iss. 2, 2014-04 ,pp. :
Docetaxel plus cisplatin: active and well tolerated in locally advanced or metastatic gastric cancer
Inpharma, Vol. 1, Iss. 1278, 2001-01 ,pp. :
By Murren John Modiano Manuel Kummar Shivaani Clairmont Caroline Egorin Merrill Chu Edward Sznol Mario
Investigational New Drugs, Vol. 23, Iss. 2, 2005-01 ,pp. :